Mar 25, 2019
GigaGen Publishes Study in Peer-Reviewed Journal mAbs, Validating Feasibility and Benefit of Rapid Parallel Immunization Protocols for Discovery of Novel Monoclonal Antibodies
Feb 24, 2019
GigaGen CEO David Johnson to Present on Surge Technology at 2019 Antibody Engineering & Therapeutics Asia Meeting
Feb 20, 2019
GigaGen Publishes Study Demonstrating Optimal Method for Selecting OX40 Therapeutic Candidates from Antibody Repertoires
Jan 30, 2019
GigaGen Promotes Adam Adler, Ph.D., to Chief Scientific Officer
Jan 10, 2019
GigaGen Announces Appointment of Erica Stone, Ph.D., as Director, Immuno-Oncology
Nov 12, 2018
GigaGen CEO David Johnson to Present on Development of Recombinant Polyclonal Therapies for Infectious Disease at 10th Annual PEGS Summit Europe
Nov 09, 2018
GigaGen to Present Data on Immuno-Oncology Pipeline at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting
Oct 26, 2018
GigaGen to Present Data on Recombinant Hyperimmune Gammaglobulin at the 18th Biennial Meeting of the European Society for Immunodeficiencies
May 03, 2018
GigaGen Announces Appointment of Sheila M. Keating, Ph.D., as Director, Immunology
Apr 30, 2018
GigaGen CEO David Johnson to Present on the Power of Surge Technology to Discover Unique Immuno-oncology Antibodies at 14th Annual PEGS Summit
Feb 12, 2018
GigaGen to Present Novel Antibody Development and T Cell Discovery Methods at 2018 Keystone Symposia Conferences
Feb 05, 2018
Natively Paired Antibodies Are Better: Study by GigaGen in Collaboration with Global Biopharmaceutical Company Describes Novel Approach to Identifying Antibodies with High Therapeutic Potential
Jan 23, 2018
GigaGen Announces New Office Space in South San Francisco
Jan 16, 2018
GigaGen Receives NIH Grant to Develop Production Technology for Recombinant Intravenous Immunoglobulin
Dec 19, 2017
GigaGen to Develop Human Antibodies Against 17 Immuno-oncology Targets
Dec 14, 2017
GigaGen CEO David Johnson to Present at 2017 Antibody Engineering & Therapeutics Meeting
Aug 29, 2017
GigaGen Studies Published in Peer-Reviewed Journal mAbs, Validate Its Novel Monoclonal Antibody Discovery Approach in Mouse and Human Antibody Repertoires